Relmada Therapeutics, Inc.
RLMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001553643
In the last 90 days, Relmada Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $693.7M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Relmada Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- +3 vs. Q1 2022
- Shares held
- 24.7M
- +1.64M (+7.1%) vs. Q1 2022
- Total value
- $468.5M
- −$153.6M (−24.7%) vs. Q1 2022
- New holders
- 16
- 50 more added
- Sold out
- 13
- 24 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RLMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $693.7M |
| Q1 2026 | 103 | $588.8M |
| Q4 2025 | 78 | $245.8M |
| Q3 2025 | 44 | $15.5M |
| Q2 2025 | 50 | $3.18M |
| Q1 2025 | 44 | $1.68M |
| Q4 2024 | 48 | $4.36M |
| Q3 2024 | 69 | $40.2M |
| Q2 2024 | 79 | $40.7M |
| Q1 2024 | 93 | $66.5M |
| Q4 2023 | 83 | $56.4M |
| Q3 2023 | 88 | $45.0M |
| Q2 2023 | 95 | $39.7M |
| Q1 2023 | 91 | $40.3M |
| Q4 2022 | 110 | $66.8M |
| Q3 2022 | 134 | $953.6M |
| Q2 2022 | 113 | $468.5M |
| Q1 2022 | 113 | $623.1M |
| Q4 2021 | 97 | $467.2M |
| Q3 2021 | 87 | $262.8M |
| Q2 2021 | 85 | $318.3M |
| Q1 2021 | 82 | $335.7M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Relmada Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Parsons Capital Management Inc | 503,776 | $9.57M | 0.86% | +700+0.1% | Added |
| State Street Corp | 601,185 | $11.4M | 0.00% | +155,621+34.9% | Added |
| Great Point Partners LLC | 700,000 | $13.3M | 3.42% | −90,000−11.4% | Reduced |
| Vivo Capital, LLC | 705,882 | $13.4M | 1.35% | 00.0% | Unchanged |
| Citadel Advisors LLC | 947,413 | $18.0M | 0.02% | +7,941+0.8% | Added |
| Cowen and Company, LLC | 1,066,854 | $20.3M | 2.00% | −97,507−8.4% | Reduced |
| Point72 Asset Management, L.P. | 1,272,574 | $24.2M | 0.11% | −39,826−3.0% | Reduced |
| Vanguard Group Inc | 1,423,032 | $27.0M | 0.00% | +99,018+7.5% | Added |
| BVF Inc | 1,659,220 | $31.5M | 1.52% | +11,820+0.7% | Added |
| Ra Capital Management, L.P. | 2,000,000 | $38.0M | 1.01% | 00.0% | Unchanged |
| BlackRock Inc. | 2,152,911 | $40.9M | 0.00% | +200,103+10.2% | Added |
| VR Adviser, LLC | 2,270,072 | $43.1M | 8.49% | 00.0% | Unchanged |
| RTW Investments, LP | 2,637,581 | $50.1M | 1.29% | +97,507+3.8% | Added |
| Mangrove Partners | 0 | $0 | 0.00% | −258,094−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −138,000−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −21,801−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −19,200−100.0% | Sold out |
| CM Management, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −14,885−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −13,806−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −12,428−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −10,487−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −9,275−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −7,526−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −6,100−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Golden State Equity Partners | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |